Patient Characteristics and Results
| Patient no. | Sex | Age (y) | Viral load | CD4 | HAART | LN no. | SUV LN 1 | SUV LN 2 | ΔSUV LN | LU no. | SUV LU 1 | SUV LU 2 | ΔSUV LU | Response to therapy | CRP |
| 1 | M | 28 | 50 | 479 | 12 | 8 | 8.6 | 10.8 | 26 | 2 | 2.9 | 5.2 | 79 | NR | 206 |
| 2 | F | 25 | 643,211 | 105 | 0 | 3 | 4.8 | 7.1 | 48 | 1 | 5.6 | 9.9 | 75 | R | 67 |
| 3 | M | 47 | 189,000 | 237 | 3 | 1 | 2.4 | 2.5 | 4 | 2 | 3.1 | 3.7 | 19 | R | 32 |
| 4 | M | 36 | 50 | 459 | 24 | 7 | 11.8 | 19.6 | 66 | — | — | — | — | NR | 189 |
| 5 | M | 42 | 8,028 | 256 | 6 | 5 | 6.3 | 8.6 | 37 | 2 | 4.4 | 9.3 | 110 | R | 29 |
| 6 | F | 34 | 623 | 352 | 12 | 3 | 4.9 | 6.5 | 33 | — | — | — | — | R | 45 |
| 7 | F | 38 | 5,121 | 119 | 6 | 2 | 7.7 | 11.9 | 55 | — | — | — | — | R | 37 |
| 8 | F | 46 | 431 | 456 | 12 | 6 | 13.5 | 20.6 | 53 | — | — | — | — | NR | 162 |
| 9 | F | 34 | 50 | 524 | 24 | 3 | 6.9 | 10 | 45 | 1 | 7.8 | 13.5 | 73 | R | 103 |
| 10 | M | 43 | 345,216 | 53 | 0 | 4 | 9.2 | 16 | 74 | 1 | 7.8 | 9.3 | 19 | R | 177 |
| 11 | F | 27 | 753 | 109 | 3 | 1 | 17.2 | 21 | 22 | 2 | 13.2 | 18.1 | 37 | R | 142 |
| 12 | M | 45 | 188 | 476 | 9 | 1 | 9.7 | 15.4 | 49 | 1 | 7.1 | 9.8 | 38 | R | 75 |
| 13 | M | 43 | 20,345 | 277 | 6 | 7 | 10.2 | 15.2 | 49 | 2 | 12.8 | 19.7 | 53 | NR | 153 |
| 14 | F | 64 | 223,458 | 117 | 0 | 0 | — | — | — | 2 | 14.8 | 19.8 | 32 | R | 78 |
| 15 | M | 35 | 532,175 | 56 | 0 | 7 | 8.9 | 12.5 | 40 | — | — | — | — | NR | 98 |
| 16 | M | 53 | 50 | 489 | 20 | 1 | 5.4 | 5.2 | 16 | 2 | 6.4 | 8.4 | 30 | R | 121 |
| 17 | F | 26 | 763 | 199 | 4 | 5 | 13.8 | 16.4 | 19 | 2 | 4.7 | 5.8 | 23 | NR | 173 |
| 18 | M | 51 | 50 | 502 | 12 | 7 | 9 | 12.7 | 41 | — | — | — | — | R | 20 |
| 19 | M | 38 | 2,033 | 426 | 14 | 1 | 4.7 | 4.3 | −9 | 2 | 3.6 | 4.4 | 22 | R | 33 |
| 20 | F | 35 | 569,000 | 59 | 0 | 6 | 11.8 | 16 | 36 | 1 | 10.2 | 16.4 | 61 | NR | 156 |
| 21 | F | 37 | 231,452 | 87 | 1 | 3 | 4.8 | 7.4 | 54 | 1 | 8.2 | 11.2 | 37 | R | 31 |
| 22 | M | 37 | 154,234 | 132 | 6 | 7 | 6.1 | 7.4 | 21 | 1 | 8.5 | 9.7 | 14 | R | 101 |
| 23 | M | 45 | 745 | 187 | 9 | 3 | 4.6 | 4.9 | 6 | 1 | 6.9 | 7.3 | 6 | NR | 48 |
| 24 | M | 32 | 960 | 189 | 24 | 1 | 3.2 | 3.3 | 3 | 0 | — | — | — | R | 16 |
Viral load = number of virus copy numbers/mL; CD4 = CD4 cell count/mL; LN no. = number of involved lymph node bastions; SUV LN 1 = average lymph node SUVmax on early images; SUV LN 2 = average lymph node SUVmax on delayed images; ΔSUV LN = percentage change over time in SUVmax of lymph nodes; LU no. = number of sites of lung involvement; SUV LU 1 = (average) lung lesion SUVmax on early images; SUV LU 2 = (average) lung lesion SUVmax on delayed images; ΔSUV LU = percentage change over time in SUVmax of lung lesions; CRP = C-reactive protein in mg/mL; NR = nonresponder; R = responder.